Kim Treatment Resistance in Psychiatry

Risk Factors, Biology, and Management
1. Auflage 2019
ISBN: 978-981-10-4358-1
Verlag: Springer Singapore
Format: PDF
Kopierschutz: Wasserzeichen (»Systemvoraussetzungen)

E-Book, Englisch, 416 Seiten, eBook

This book reviews all the important aspects of treatment-resistant psychiatric disorders, covering issues such as definitions, clinical aspects, neurobiological correlates, treatment options, and predictors of treatment response. The book is divided into three sections, the first of which examines the most recent thinking on treatment resistance in psychiatry, including definition and epidemiology, paradigm shift in the study of the subjects, individual susceptibility and resilience, abnormal structural or functional connectivity, and insights from animal models. The second section then discusses treatment resistance in each of the major psychiatric disorders, with particular focus on the responsible clinical and biological factors and the available management strategies. Finally, more detailed information is presented on diverse pharmacological and non-pharmacological therapeutic interventions. The book, written by leading experts from across the world, will be of value to all who seek a better understanding of the clinical-neurobiological underpinnings and the development of management for treatment resistance in psychiatric disorders.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Kim, Yong-Ku

Inhaltsverzeichnis

Part I. Rethinking the treatment resistance in psychiatry Chapter 1. Definition and epidemiology of treatment resistance in psychiatrySanne Smith-Apeldoorn, Jolien Veraart, Robert Schoevers

Department of Psychiatry, University Medical Center Groningen, University of Groningen, the Netherlands Chapter 2. Paradigm shift in study of treatment resistant psychiatric disorderSang-Won Jeon 1 Meysam Amidfar,2 Yong-Ku Kim31 Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea2 Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran3 Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea Chapter 3. Genetic factors underlying treatment resistance in psychiatryEduard Maron, Chenchia Lan, David Nutt Faculty of Medicine, Department of Medicine, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK  Chapter 4. Using neuroimaging and electroencephalography forprediction of treatment resistance in psychiatric disorders  Je_Yeon Yun, 1Seung-Hwan Lee2 1Seoul National University Hospital, Seoul, Republic of Korea2 Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine, Republic of Korea.  Chapter 5. Developing therapies for treatment-resistant depressive disorders in animal modelsMichel Bourin Neurobiology of anxiety and mood disorders, University of Nantes, France Chapter 6. Integrated approaches to treatment-resistant psychiatric disordersSeon-Cheol Park,1 Yong-Ku Kim21 Department of Psychiatry, Inje University College of Medicine and Haeundae Paik Hospital, Busan, Republic of Korea2 Department of Psychiatry, College of Medicine, Korea University, Seoul, Korea  Part II. Treatment resistance in specific disorders Chapter 7. Treatment resistant depression: understandings on the neurobiological etiology that lead to novel pharmacological treatment optionsEunsoo Won, Byoung-Joo Ham, Yong-Ku Kim,Department of Psychiatry, College of Medicine, Korea University, Seoul, Korea Chapter 8. Treatment Resistant Schizophrenia: assessment and management

Sandeep Grover, Harsh Garekar, Anisha Agarwal Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India  Chapter 9. Treatment resistance in bipolar disordersMarsal Sanches, Joao Quevedo, Jair C, SoaresCenter of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA. Chapter 10. Treatment resistance in post-traumatic stress disorder

Alexander Cowell McFarlane,The Centre for Traumatic Stress Studies, The University of Adelaide, Adelaide, AustraliaChapter 11. Treatment resistance in obsessive compulsive disorderRachel Middleton, Michael G. Wheaton, Reilly Kayser, H. Blair SimpsonNew York State Psychiatric Institute/Columbia Psychiatry, Columbia University Medical Center, New York, USA  Chapter 12. Treatment of opioid dependenceMichael Soyka,Psychiatric Hospital, University of Munich, Munich, Germany Chapter 13. Treatment-resistant panic disorderMu-Hong Chen, Shih-Jen Tsai,Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan Chapter 14. Treatment resistance in anxiety disorder: generalized anxiety disorder, social anxiety disorder

Kang Soo Lee, Sang Huk LeeDepartment of Psychiatry, School of Medicine, CHA University, CHA Bundang Medical Center, Seongnam, Korea Chapter 15. Treatment resistance in Attention-Deficit Hyperactivity DisorderAmber D. Hunt, David W. Dunn, Hillary S. Blake, Jen Downs

Department of Psychiatry and Neurology, Riley Hospital Child and Adolescent Psychiatry Clinics, Indiana University School of Medicine, Indianapolis, USA. Chapter 16. Treatment resistance in Tourette syndromeRenata Rizzo,1 Mariangela Gulisano21Child and Adolescent Neurology and Psychiatry, School of Medicine, University of Catania, Catania, Italy2 Child and Adolescent Neurology and Psychiatry Clinics, Policlinico, Catania, Italy Chapter 17. Treatment-Resistance Eating DisordersYoul-Ri Kim,, Jione Kim

Department of Psychiatry, Seoul Paik Hospital, Institute of Eating Disorders and Mental Health, Inje University, Seoul Paik Hospital, Inje University, Republic of Korea Chapter 18. Comorbid sleep and wake problems in treatment-resistant psychiatric conditions Seung Gul Kang,1 Heon-Jeong Lee,2 Yong-Ku Kim,2 Leen Kim2  1Department of Psychiatry, Gil Medical Center, Gachon University, College of Medicine, Incheon, Republic of Korea2Department of Psychiatry, Korea University College of Medicine, Seoul, Republic of Korea Part III. Therapeutic intervention for treatment resistance Chapter 19. Creative, person-centered psychopharmacology for treatment resistance in psychiatryMiro JakovljevicUniversity Hospital Centre Zagreb, Department of Psychiatry, Zagreb, Croatia Chapter 20. A psychodynamic approach to treatment resistanceElizabeth Weinberg, Erin Seery, Eric M. Plakun, The Austen Rigges Center, Stockbridge, MA, USA  Chapter 21. Cognitive behavioral therapy and behavioral activation therapy for treatment resistant depression: traditional and digital therapy perspectives

Jennifer A. Apolinário-Hagen, Lara Fritsche, Liesemarie Albers, Christel Salewski Department of Health Psychology, University of Hagen, Hagen, Germany.  Chapter 22. Novel neurostimulation therapeutic approaches for treatment resistant psychiatric disordersRalph J. Koek, Janine Roach, Nicholas Athanasiou, Arkady KorotinskyDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the UCLA, Los Angeles, USA Chapter 23. When clozapine fails: augmentation strategies in the management of clozapine-resistant schizophrenia Domenico De Berardis,1 Michele Fornaro, Annalisa Anastasia, Federica Vellante , Alessandro Valchera, Marilde Cavuto, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Laura Orsolini, Carmine Tomasetti, Gabriella Di Emidio, Giovanni Martinotti, Massimo Di Giannantonio 1NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital “G. Mazzini”, ASL 4 Teramo, Italy Chapter 24. Fecal microbiota transplantation in the treatment resistant psychiatric disordersAlper Evrensel, Mehmet Emin Ceylan Department of Psychiatry, Uskudar University, Istanbul, Turkey Chapter 25. Neurosurgical intervention for treatment-resistant psychiatric disordersDaniel E. Nijensohn,1 Teodoro Forcht Dagi 21Honorary Professor, Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA 2 Distinguished Scholar and Professor at the School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast, Northern Ireland

Über Autor(innen)

Yong-Ku Kim, MD, PhDDepartment of Psychiatry, Korea University Ansan Hospital, South Korea